Holdings

Blue Owl Capital Holdings LP

As of Sep 30, 2026, Blue Owl Capital Holdings LP reported 48 positions worth US$544M. Largest: Space Exploration Technologies Corp, Aktis Oncology, Inc. and Latigo Biotherapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Space Exploration Technologies Corp923KUS$139M−476KSep 30, 2026
Aktis Oncology, Inc.3.34MUS$65.1M+274KSep 30, 2026
Latigo Biotherapeutics, Inc.3.6MUS$60.1MnewSep 30, 2026
Larimar Therapeutics, Inc.9.92MUS$31.7M+761KSep 30, 2026
Electra Therapeutics, Inc.2.61MUS$29.4MnewSep 30, 2026
Nuveen Churchill Direct Lending Corp.2.14MUS$24.1Mno changeSep 30, 2026
Cullinan Therapeutics, Inc.1.4MUS$21.5M−140KSep 30, 2026
Blue Owl Capital Corporation2.05MUS$21.5Mno changeSep 30, 2026
Obsidian Therapeutics, Inc.1.48MUS$20.4MnewSep 30, 2026
Sagimet Biosciences Inc. - Series A1.13MUS$11.1M−135KSep 30, 2026